Skip to main content

01.11.2015 | Research Article

Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies

verfasst von: C. V. Sole, F. A. Calvo, S. Lizarraga, L. Gonzalez-Bayon, J. L. García-Sabrido

Erschienen in: Clinical and Translational Oncology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyze long-term outcomes and prognostic factors in patients with paraaortic lymph-node oligometastases (LNO) from gynecological malignancies treated in a multimodal protocol.

Methods

Patients with a histological diagnosis of LNO gynecological cancer [uterine cervix (n = 14, 40 %), endometrial (n = 18, 51 %), ovarian (n = 3, 9 %)] who underwent surgery with radical intent and intraoperative radiotherapy (IORT), median dose 12.5 Gy) were considered eligible for participation in this study. Additionally, 51 % received external-beam radiotherapy (EBRT).

Results

From 1997 to 2012, a total of 35 patients from a single institution were analyzed. With a median follow-up time of 55 months (range 2–148), 5-year loco-regional control (LRC), disease-free survival (DFS) and overall survival (OS) were 79, 44 and 49 %, respectively. On multivariate analysis, no EBRT treatment to the LNO (p = 0.03), and time interval from primary tumor diagnosis to LNO <24 months (p = 0.04) remained significantly associated with locoregional recurrence (LRR). We found on multivariate analysis that only R1 margin status (p = 0.01) was significantly associated with OS.

Conclusion

From the current series of patients with gynecological LNO, it emerges the fact that EBRT promotes local control. Future prospective studies might be designed according to the predicted risk of LRR focusing on different subgroups.
Literatur
1.
Zurück zum Zitat Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.PubMed Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.PubMed
3.
Zurück zum Zitat Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–82.PubMed Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–82.PubMed
4.
Zurück zum Zitat Palma DA, Salama JK, Lo SS, Senan S, Treasure T, Govindan R, et al. The oligometastatic state—separating truth from wishful thinking. Nat Rev Clin Oncol. 2014;11:549–57.CrossRefPubMed Palma DA, Salama JK, Lo SS, Senan S, Treasure T, Govindan R, et al. The oligometastatic state—separating truth from wishful thinking. Nat Rev Clin Oncol. 2014;11:549–57.CrossRefPubMed
5.
Zurück zum Zitat Gunderson LL, Willett CG, Calvo FA. eds. Intraoperative irradiation: Techniques and results. 2nd ed. Springer New York: Humana Press; 2011. Gunderson LL, Willett CG, Calvo FA. eds. Intraoperative irradiation: Techniques and results. 2nd ed. Springer New York: Humana Press; 2011.
6.
Zurück zum Zitat Pascau J, Santos Miranda JA, Calvo FA, Bouché A, Morillo V, González-San Segundo C, et al. An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys. 2012;83:287–95.CrossRef Pascau J, Santos Miranda JA, Calvo FA, Bouché A, Morillo V, González-San Segundo C, et al. An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys. 2012;83:287–95.CrossRef
7.
Zurück zum Zitat Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.CrossRefPubMed Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.CrossRefPubMed
8.
Zurück zum Zitat Haddock MG, Martinez-Monge R, Petersen IA. Locally advanced primary and recurrent gynecological malignancies: EBRT with or without IOERT or HDR-IORT. In: Gunderson LL, Willett CG, Calvo FA, Harrison LB, editors. Intraoperative irradiation Techniques and results. Springer New York: Humana Press; 2011. Haddock MG, Martinez-Monge R, Petersen IA. Locally advanced primary and recurrent gynecological malignancies: EBRT with or without IOERT or HDR-IORT. In: Gunderson LL, Willett CG, Calvo FA, Harrison LB, editors. Intraoperative irradiation Techniques and results. Springer New York: Humana Press; 2011.
9.
Zurück zum Zitat Mahe MA, Gerard JP, Dubois JB, Roussel A, Bussières E, Delannes M, et al. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients. Int J Radiat Oncol Biol Phys. 1996;34:21–6.CrossRefPubMed Mahe MA, Gerard JP, Dubois JB, Roussel A, Bussières E, Delannes M, et al. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients. Int J Radiat Oncol Biol Phys. 1996;34:21–6.CrossRefPubMed
10.
Zurück zum Zitat Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, et al. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006;101:280–6.CrossRefPubMed Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, et al. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006;101:280–6.CrossRefPubMed
11.
Zurück zum Zitat Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative electron beam radiation therapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol. 2013;8:80.PubMedCentralCrossRefPubMed Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative electron beam radiation therapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol. 2013;8:80.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int J Radiat Oncol Biol Phys. 1997;37:839–43.CrossRefPubMed Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int J Radiat Oncol Biol Phys. 1997;37:839–43.CrossRefPubMed
13.
Zurück zum Zitat Martínez-Monge R, Jurado M, Aristu JJ, Moreno M, Cambeiro M, Pérez-Ochoa A, et al. Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer. Gynecol Oncol. 2001;82:538–43.CrossRefPubMed Martínez-Monge R, Jurado M, Aristu JJ, Moreno M, Cambeiro M, Pérez-Ochoa A, et al. Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer. Gynecol Oncol. 2001;82:538–43.CrossRefPubMed
14.
Zurück zum Zitat Calvo FA, Sole CV, Lozano MA, Gonzalez-Bayon L, Gonzalez-Sansegundo C, Alvarez A, et al. Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: long-term outcomes. Gynecol Oncol. 2013;130:537–44.CrossRefPubMed Calvo FA, Sole CV, Lozano MA, Gonzalez-Bayon L, Gonzalez-Sansegundo C, Alvarez A, et al. Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: long-term outcomes. Gynecol Oncol. 2013;130:537–44.CrossRefPubMed
Metadaten
Titel
Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies
verfasst von
C. V. Sole
F. A. Calvo
S. Lizarraga
L. Gonzalez-Bayon
J. L. García-Sabrido
Publikationsdatum
01.11.2015
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 11/2015
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-015-1326-7

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.